The nature of beryllium disease

The increasing use of beryllium in modern industry poses a continuing health hazard with a real risk of producing incapacitating disease and even death. Beryllium and its salts are very toxic, even in small doses and may produce lesions in any organ. The majority of cases follow inhalation and may cause either acute or chronic lung disease. Acute pulmonary disease is a form of chemical pneumonitis while the chronic disease is characterised by the production of granulomas and fibrosis. The skin may be affected with the finding of dermatitis, acute or chronic ulceration. Other organs commonly involved include the liver and kidneys. The pathology of beryllium disease is not specific and diagnosis depends on satisfying the following criteria - history of exposure, consistent clinical, radiographic and pathological finding, presence of beryllium in tissue/fluid and evidence of hypersensitivity. Recent development of 'in vitro' tests of hypersensitivity may prove of value in both diagnosis and prevention of disease. Beryllium disease responds to steroid therapy but the only sure treatment is avoidance of exposure. (author)